Amalgamated Bank Nektar Therapeutics Transaction History

Amalgamated Bank

$12.1 Billion
Q3 2024

A detailed history of Amalgamated Bank transactions in Nektar Therapeutics stock. As of the latest transaction made, Amalgamated Bank holds 6,177 shares of NKTR stock, worth $5,744. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,177

Previous 6,177 -0.0%

Holding current value

$5,744

Previous $8,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$0.9 - $1.83 $5,559 - $11,303	6,177 New	6,177 $8,000
Q1 2023 May 02, 2023	SELL	$0.64 - $3.15 $3,008 - $14,805	-4,700 Reduced 5.98%	73,886 $52,000
Q4 2022 Feb 10, 2023	SELL	$2.03 - $4.28 $9,242 - $19,486	-4,553 Reduced 5.48%	78,586 $178,000
Q3 2022 Nov 09, 2022	BUY	$3.04 - $5.14 $8,843 - $14,952	2,909 Added 3.63%	83,139 $266,000
Q2 2022 Aug 15, 2022	SELL	$3.17 - $6.17 $13,507 - $26,290	-4,261 Reduced 5.04%	80,230 $305,000
Q1 2022 Jun 30, 2022	BUY	$4.16 - $13.72 $105,035 - $346,416	25,249 Added 42.62%	84,491 $455,000
Q4 2021 Feb 15, 2022	SELL	$10.83 - $18.41 $762,702 - $1.3 Million	-70,425 Reduced 54.31%	59,242 $800,000
Q3 2021 Oct 29, 2021	SELL	$13.07 - $18.84 $168,289 - $242,583	-12,876 Reduced 9.03%	129,667 $2.33 Million
Q2 2021 Aug 16, 2021	BUY	$16.52 - $20.4 $2 Million - $2.47 Million	120,850 Added 557.09%	142,543 $2.45 Million
Q1 2021 May 13, 2021	SELL	$16.56 - $25.46 $23,515 - $36,153	-1,420 Reduced 6.14%	21,693 $434,000
Q4 2020 Feb 12, 2021	BUY	$15.77 - $19.03 $1,277 - $1,541	81 Added 0.35%	23,113 $392,000
Q3 2020 Oct 30, 2020	SELL	$16.59 - $24.79 $1,841 - $2,751	-111 Reduced 0.48%	23,032 $382,000
Q2 2020 Aug 10, 2020	SELL	$16.86 - $23.44 $266,539 - $370,562	-15,809 Reduced 40.59%	23,143 $536,000
Q1 2020 May 13, 2020	SELL	$14.47 - $27.96 $9,492 - $18,341	-656 Reduced 1.66%	38,952 $695,000
Q4 2019 Feb 13, 2020	BUY	$15.87 - $23.12 $41,928 - $61,083	2,642 Added 7.15%	39,608 $855,000
Q3 2019 Nov 13, 2019	BUY	$16.91 - $36.27 $8,404 - $18,026	497 Added 1.36%	36,966 $673,000
Q2 2019 Aug 14, 2019	BUY	$31.0 - $36.3 $402,101 - $470,847	12,971 Added 55.2%	36,469 $1.3 Million
Q1 2019 May 15, 2019	BUY	$31.58 - $46.35 $14,589 - $21,413	462 Added 2.01%	23,498 $790,000
Q4 2018 Feb 15, 2019	SELL	$30.43 - $56.65 $19,505 - $36,312	-641 Reduced 2.71%	23,036 $757,000
Q3 2018 Nov 14, 2018	SELL	$46.46 - $68.49 $34,845 - $51,367	-750 Reduced 3.07%	23,677 $1.44 Million
Q2 2018 Jul 18, 2018	BUY	$46.25 - $104.45 $84,082 - $189,890	1,818 Added 8.04%	24,427 $1.19 Million
Q1 2018 May 22, 2018	BUY	$57.4 - $108.44 $47,871 - $90,438	834 Added 3.83%	22,609 $2.4 Million
Q4 2017 Feb 13, 2018	BUY	$23.02 - $60.5 $29,879 - $78,529	1,298 Added 6.34%	21,775 $1.3 Million
Q3 2017 Nov 09, 2017	BUY	$17.79 - $24.0 $364,285 - $491,448	20,477	20,477 $491,000

Others Institutions Holding NKTR

# of Institutions

145

Shares Held

139M

Call Options Held

32.6K

Put Options Held

14.1K

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $174M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Nektar Therapeutics Transaction History